Ribomic Inc. (TYO:4591)
82.00
-1.00 (-1.20%)
At close: Feb 6, 2026
Ribomic Employees
Ribomic had 25 employees as of March 31, 2025. The number of employees increased by 1 or 4.17% compared to the previous year.
Employees
25
Change (1Y)
1
Growth (1Y)
4.17%
Revenue / Employee
n/a
Profits / Employee
-42.12M JPY
Market Cap
4.45B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 25 | 1 | 4.17% |
| Mar 31, 2024 | 24 | -1 | -4.00% |
| Mar 31, 2023 | 25 | -1 | -3.85% |
| Mar 31, 2022 | 26 | 1 | 4.00% |
| Mar 31, 2021 | 25 | 3 | 13.64% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Linical | 598 |
| Transgenic Group | 241 |
| Kohjin Bio | 167 |
| Soiken Holdings | 81 |
| Carna Biosciences | 63 |
| PRISM BioLab Co.,LTD | 35 |
| Noile-Immune Biotech | 25 |
| D. Western Therapeutics Institute | 21 |